Ayala Pharmaceuticals, Inc.

Norris Financial Group, LLC ADXS

Report date

9/30/2021

Quarter

2021 Q3

Filed

5/20/2026

Shares

74,850

Value ($000)

39

Weight

0.0%

2020 Q1 - 2021 Q3 (7 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2021 Q3	5/20/2026	39	0.0%	74,850	9/30/2021
2021 Q2	5/20/2026	35	0.0%	74,850	6/30/2021
2021 Q1	5/20/2026	55	0.0%	74,850	3/31/2021
2020 Q4	6/2/2026	22	0.0%	64,150	12/31/2020
2020 Q3	6/2/2026	26	0.0%	64,150	9/30/2020
2020 Q2	6/2/2026	34	0.0%	64,150	6/30/2020
2020 Q1	6/2/2026	18	0.0%	33,250	3/31/2020